 - Enteric hyperoxaluria 0.5 mMday; 45 mgday due to fat malabsorption from inflammatory bowel disease Crohns Disease. Patients in remission maintained on stable doses of RemicadeImuranMethotrexate every 8 weeks can be recruited as long as the trial can be conducted between 5 and 8 weeks after the last dose; OR 